Endometriosis Market 2023 - Global Epidemiology Trends Research Report

Endometriosis Market Insights, Epidemiology and Market Forecast 2023 Report provides an overview of the disease and global market size of the Endometriosis for the7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Endometriosis from 2013-2023.

Request Sample Report@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=894783

Description of Report:

Report states that worldwide in 2012, 527,600 women were diagnosed with Endometriosis. The mortality rate was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries Endometriosis was the most common gynaecologic malignancy, with over 60,000 new cases and over 10,000 deaths from the disease in each year.

Lupron, developed by Abbvie is the top selling of Endometriosis contributing to majority of the market size. Other top players include Visanne/Dienogest (Bayer Healthcare), Zoladex (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer). According to report the worldwide Endometriosis market is estimated to be USD 1.91 Billion by 2023 at a CAGR of 1.33%.

Key Companies with Drugs Discussed In Report: Abbvie, Visanne/Dienogest (Bayer Healthcare), Zoladex (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer)

Inquire for Discount on Complete Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=894783

Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options. Marketed information including available prescription drugs, its patent and exclusivity details. The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023. It also provides Market size of Endometriosis for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.

Major Table OF Content

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in United States (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in United Kingdom (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in Germany (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in France (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in Italy (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in Spain (2013-2023)

·         Prevalent, Diagnosed and Treatable cases of Endometriosis in Japan (2013-2023)

·         Total Market size of Endometriosis in USD Billion (2013-2023)

·         United States Market Size of Endometriosis in USD, Billion (2013-2023)

·         United Kingdom Market Size of Endometriosis in USD, Billion (2013-2023)

·         Germany Market Size of Endometriosis in USD, Billion (2013-2023)

·         France Market Size of Endometriosis in USD, Billion (2013-2023)

·         Italy Market Size of Endometriosis in USD, Billion (2013-2023)

·         Spain Market Size of Endometriosis in USD, Billion (2013-2023)

·         Japan Market Size of Endometriosis in USD, Billion (2013-2023)

Buy Complete PDF Report@: http://www.reportsnreports.com/purchase.aspx?name=894783

About Us:

Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.